{"entity":{"type":"insider","cik":"0001786966","url":"/insider/0001786966","json_url":"/insider/0001786966.json","name":"Edris Badreddin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":8,"first":"2021-01-26","last":"2026-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Edris Badreddin","source":"filing","n_filings":8,"first_seen":"2021-01-26","last_seen":"2026-01-23"}],"transactions":[{"id":6200666,"accession":"0001786966-26-000001","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001786966-26-000001","line_url":"/filing/0001786966-26-000001","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001786966","owner_name":"Edris Badreddin","owner_display_name":"Edris Badreddin","owner_url":"/insider/0001786966","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115471.0,"shares_display":"115,471","price_per_share":29.44,"price_display":"29.44","price_state":"stated","total_value":3399466.24,"total_display":"3,399,466.24","total_whole":"3,399,466","shares_owned_after":19820.0,"shares_owned_after_display":"19,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-21","filed_date":"2026-01-23","scope":"insider","n_lines":5},{"id":5162185,"accession":"0001104659-25-021008","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-021008","line_url":"/filing/0001104659-25-021008","is_derivative":false,"issuer_cik":"0001773427","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001773427","owner_cik":"0001786966","owner_name":"Edris Badreddin","owner_display_name":"Edris Badreddin","owner_url":"/insider/0001786966","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":54.22961189,"price_display":"54.23","price_state":"stated","total_value":1084592.2378,"total_display":"1,084,592.24","total_whole":"1,084,592","shares_owned_after":173710.0,"shares_owned_after_display":"173,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider","n_lines":4},{"id":4763309,"accession":"0001104659-25-012359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-012359","line_url":"/filing/0001104659-25-012359#line-1","is_derivative":false,"issuer_cik":"0001773427","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001773427","owner_cik":"0001786966","owner_name":"Edris Badreddin","owner_display_name":"Edris Badreddin","owner_url":"/insider/0001786966","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":53.1265,"price_display":"53.13","price_state":"stated","total_value":1593795.0,"total_display":"1,593,795.00","total_whole":"1,593,795","shares_owned_after":189712.0,"shares_owned_after_display":"189,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":2686213,"accession":"0001104659-24-125969","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-125969","line_url":"/filing/0001104659-24-125969","is_derivative":false,"issuer_cik":"0001773427","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001773427","owner_cik":"0001786966","owner_name":"Edris Badreddin","owner_display_name":"Edris Badreddin","owner_url":"/insider/0001786966","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":41.96678965,"price_display":"41.97","price_state":"stated","total_value":839335.793,"total_display":"839,335.79","total_whole":"839,336","shares_owned_after":217634.0,"shares_owned_after_display":"217,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-03","filed_date":"2024-12-05","scope":"insider","n_lines":2},{"id":2837638,"accession":"0001104659-24-096869","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-096869","line_url":"/filing/0001104659-24-096869","is_derivative":false,"issuer_cik":"0001773427","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001773427","owner_cik":"0001786966","owner_name":"Edris Badreddin","owner_display_name":"Edris Badreddin","owner_url":"/insider/0001786966","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":40.6477173,"price_display":"40.65","price_state":"stated","total_value":812954.346,"total_display":"812,954.35","total_whole":"812,954","shares_owned_after":237300.0,"shares_owned_after_display":"237,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-04","scope":"insider","n_lines":3},{"id":3232559,"accession":"0001104659-24-068673","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-068673","line_url":"/filing/0001104659-24-068673","is_derivative":false,"issuer_cik":"0001773427","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001773427","owner_cik":"0001786966","owner_name":"Edris Badreddin","owner_display_name":"Edris Badreddin","owner_url":"/insider/0001786966","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":40.068594275,"price_display":"40.07","price_state":"stated","total_value":801371.8855,"total_display":"801,371.89","total_whole":"801,372","shares_owned_after":257828.0,"shares_owned_after_display":"257,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider","n_lines":4},{"id":5282230,"accession":"0001104659-21-088377","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-088377","line_url":"/filing/0001104659-21-088377#line-1","is_derivative":false,"issuer_cik":"0001773427","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001773427","owner_cik":"0001786966","owner_name":"Edris Badreddin","owner_display_name":"Edris Badreddin","owner_url":"/insider/0001786966","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32000.0,"shares_display":"32,000","price_per_share":85.3465,"price_display":"85.35","price_state":"stated","total_value":2731088.0,"total_display":"2,731,088.00","total_whole":"2,731,088","shares_owned_after":301541.0,"shares_owned_after_display":"301,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-01","scope":"insider"},{"id":5343817,"accession":"0001104659-21-007671","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-007671","line_url":"/filing/0001104659-21-007671#line-1","is_derivative":false,"issuer_cik":"0001773427","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001773427","owner_cik":"0001786966","owner_name":"Edris Badreddin","owner_display_name":"Edris Badreddin","owner_url":"/insider/0001786966","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32000.0,"shares_display":"32,000","price_per_share":84.0713,"price_display":"84.07","price_state":"stated","total_value":2690281.6,"total_display":"2,690,281.60","total_whole":"2,690,282","shares_owned_after":261542.0,"shares_owned_after_display":"261,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001710072","name":"Edgewise Therapeutics, Inc.","url":"/issuer/0001710072","role":"Director","n_filings":1,"first_seen":"2026-01-23","last_seen":"2026-01-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001773427","name":"SpringWorks Therapeutics, Inc.","url":"/issuer/0001773427","role":"Officer (Chief Operating Officer)","n_filings":7,"first_seen":"2021-01-26","last_seen":"2025-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001786966","retrieved_at":"2026-08-24T04:16:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}